ROKIT Healthcare develops novel approach for treating dermal scarring

Written by Mike Gregg

ROKIT Healthcare (Seoul, South Korea) has announced a novel application of its 3D bioprinter, INVIVO®, in dermal regeneration for the treatment of scarring. Skin scarring is a common medical condition which occurs after almost every dermal injury and can cause lasting effects on a patient's quality of life both physically and psychologically. To provide treatment for scarring, ROKIT Healthcare (Seoul, South Korea) has printed dermal patch grafts with their specialist INVIVO® 3D bioprinter. This cutting-edge technology allows for the printing of uniform structures that have the same cell density and thickness across the graft. They use autologous tissue cells to...

To view this content, please register now for access

It's completely free